What Caught Our Attention in the Investment World? – Week of February 24-28, 2020
By Kuldip K. Ambastha and Anil K. Ambastha On Tuesday, February 25, 2020, the stock of Moderna, Inc. (MRNA) rose by 27.8% for the day. As the coronavirus (COVID-19) has spread around the world and led to a sell-off in the capital markets, Moderna, Inc. announced that its coronavirus vaccine candidate is scheduled to be …
Continue reading “What Caught Our Attention in the Investment World? – Week of February 24-28, 2020”